Skip to Content

As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at

Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Navigating the road ahead: addressing challenges for use of metabolomics in epidemiology studies.
Authors: Haznadar M,  Maruvada P,  Mette E,  Milner J,  Moore SC,  Nicastro HL,  Sampson JN,  Su LJ,  Verma M,  Zanetti KA
Journal: Metabolomics
Date: 2014 Apr 1
Branches: BB, MEB
PubMed ID: 25914611
PMC ID: PMC4407369
Abstract: Metabolomics platforms allow for the measurement of hundreds to thousands of unique small chemical entities, as well as offer extensive coverage of metabolic markers related to obesity, diet, smoking, and other exposures of high interest to health scientists. Nevertheless, its potential use as a tool in population-based study design has not been fully explored. As the field of metabolomics continues to mature, and in part, accelerate through the National Institutes of Health (NIH) investment of ≤65 million in the Common Fund's Metabolomics Program (https://common, it is time to consider those challenges most pertinent to epidemiologic studies.